---
schema_version: "secwatch.filing_event.v1"
accession: "0000816956-25-000054"
form_type: "8-K"
ticker: "CNMD"
cik: "0000816956"
company_name: "CONMED Corp"
filed_at: "2025-11-05T23:59:59+00:00"
generated_at: "2026-05-17T00:28:28.952363+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CONMED Q3 revenue up 6.7% to $338M; adjusted EPS $1.08; suspends dividend, authorizes $150M buyback

## Summary
- Diluted GAAP EPS $0.09 vs $1.57 YoY due to $19.7M product rationalization and $9.2M consulting costs.
- Adjusted diluted EPS $1.08 vs $1.05 YoY; full-year adjusted EPS guidance raised to $4.48-$4.53.
- Full-year revenue guidance narrowed to $1.365B-$1.372B; tariffs expected to reduce Q4 EPS by ~$0.07.
- Board authorized $150M share repurchase program; quarterly cash dividend suspended; at least $25M annual buybacks from 2026.

## SEC filing metadata
- accession: 0000816956-25-000054
- form_type: 8-K
- ticker: CNMD
- cik: 0000816956
- company_name: CONMED Corp
- filed_at: 2025-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/816956/000081695625000054/0000816956-25-000054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/816956/000081695625000054/cnmd-20251105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000816956-25-000054
- JSON: https://secwatch.observer/filing/0000816956-25-000054.json
- Plain text: https://secwatch.observer/filing/0000816956-25-000054.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.